Recerca

Àrea 2

Aterosclerosi i malaltia coronària

Articles de l'any 2010
Original

Originals publicats: 33

Factor d'impacte: mitjana: 3.98, total: 131.29

  • Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries

    Widimsky P, Wijns W, Fajadet J, DeBelder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, DeServi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, Zeymer U
    EUR HEART J. 2010; 31: 943-957. IF: 9.8

  • Characterization of Ion Channels Involved in the Proliferative Response of Femoral Artery Smooth Muscle Cells

    Cidad P, Moreno-Dominguez A, Novensa L, Roque M, Barquin L, Heras M, Perez-Garcia MT, Lopez-Lopez JR
    ARTERIOSCL THROM VAS. 2010; 30: 1203-0. IF: 7.235

  • Equine Estrogens Impair Nitric Oxide Production and Endothelial Nitric Oxide Synthase Transcription in Human Endothelial Cells Compared With the Natural 17 beta-Estradiol

    Novensa L, Selent J, Pastor M, Sandberg K, Heras M, Dantas AP
    HYPERTENSION. 2010; 56: 405-0. IF: 6.614

  • Cell cycle-dependent expression of Kv3.4 channels modulates proliferation of human uterine artery smooth muscle cells

    Miguel-Velado E, Perez-Carretero FD, Colinas O, Cidad P, Heras M, Lopez-Lopez JR, Perez-Garcia MT
    CARDIOVASC RES . 2010; 86: 383-391. IF: 5.801

  • What lessons have been learnt from animal models of MRSA in the lung?

    Martinez-Olondris P, Rigol M, Torres A
    EUR RESPIR J. 2010; 35: 198-201. IF: 5.527

Revisió

Revisions publicades: 2

Factor d'impacte: mitjana: 4.2, total: 8.4

  • Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes

    Bosch X, Marrugat J, Sanchis J
    COCHRANE DB SYST REV. 2010; 0: 0-0. IF: 5.653

  • The Right Heart and Pulmonary Circulation. Is It Really a Minor Circulation?

    Segovia J, Bermejo J, Alfonso F, Heras M
    REV ESP CARDIOL. 2010; 63: 77-80. IF: 2.746

Editorials

Editorials publicades: 1

Factor d'impacte: mitjana: 6.91, total: 6.91

  • Safeguarding good scientific practice in Europe The increasingly global reach of science requires the harmonization of standards

    Bosch X
    EMBO REP. 2010; 11: 252-257. IF: 6.907

Multicèntrics

Multicèntrics publicats: 2

Factor d'impacte: mitjana: 30.93, total: 61.87

  • Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

    Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KAA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S
    NEW ENGL J MED. 2010; 363: 930-942. IF: 47.05

  • Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Gerstein HC, Ratner RE, Cannon CP, Serruys PW, Garcia-Garcia HM, VanEs GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW
    CIRCULATION. 2010; 121: 1176-1187. IF: 14.816

Guies clíniques

Guies clínique publicades: 2

Factor d'impacte: mitjana: 6.1, total: 12.2

  • Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

    Wijns W, Kolh P
    EUR HEART J. 2010; 31: 2501-2555. IF: 9.8

  • Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

    Kolh P, Wijns W, Danchin N, DiMario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Uva MS, Taggart D
    EUR J CARDIO-THORAC. 2010; 38: 0-0. IF: 2.397

Més articles
Patents
  • Use of voltage-gated potassium channel blocking substances in the manufacture of a pharmacological tool for the treatment of vascular diseases e.g. restenosis and post transplant chronic nephropathy

    HOSPITAL CLINIC I PROVINCIAL BARCELONA; UNIV VALLADOLID